Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1169 | 1018 | 1169 | 1217 | 1722 | 2882 |
Fund Return | 16.94% | 1.84% | 16.94% | 6.77% | 11.49% | 11.17% |
Place in category | 4531 | 5873 | 4531 | 2425 | 1223 | 417 |
% in Category | 68 | 81 | 68 | 46 | 29 | 19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nykredit Invest Taktisk Allokering | 11.26B | 10.01 | 0.65 | 5.12 | ||
Nykredit Invest Globale Fokusak Akk | 7.21B | 16.95 | 6.72 | 11.03 | ||
Nykredit Invest Baredygtige Aktier | 5.13B | 14.12 | 4.98 | 11.65 | ||
Nykredit Invest Globale Aktier Basi | 4.98B | 26.88 | 9.84 | 11.59 | ||
Nykredit Invest Danske Aktier Akk | 1.78B | 2.91 | -0.58 | 10.64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danica Balance 100 Offensiv | 35.24B | 18.85 | 4.05 | 8.57 | ||
Nordea Invest Portefolje Aktier | 29.34B | 18.40 | 6.57 | 9.74 | ||
Danske Invest Engros Flexinv Aktier | 15.64B | 23.73 | 7.32 | 9.40 | ||
Formuepleje LimiTTellus | 10.38B | 19.19 | 6.96 | 9.66 | ||
Danske Invest Global Indeks KL | 23.16B | 26.56 | 9.44 | 11.42 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 5.54 | 410.92 | -1.00% | |
NVIDIA | US67066G1040 | 4.91 | 116.66 | -2.84% | |
Alphabet A | US02079K3059 | 4.28 | 201.23 | -1.37% | |
Amazon.com | US0231351067 | 4.18 | 237.42 | -0.11% | |
Novo Nordisk B | DK0062498333 | 3.88 | 599.7 | -1.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review